ArticleJournal of biomedical optics2025
Two-stage diffuse fluorescence tomography for monitoring of drug distribution in photodynamic therapy of tumors.
Article in Journal of biomedical optics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A cost-effective diffuse optical tomographic system for imaging absorbing and fluorescent targets in a scattering medium.Scientific reports · 2025Article
- Resorbable optical fibers for interstitial photodynamic therapy-assessment of photosensitizer spatial distribution in tumors.Journal of biomedical optics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: The spatial distribution of the photosensitizing drug concentration is an important parameter for predicting the photodynamic therapy (PDT) outcome. Current diffuse fluorescence tomography methods lack accuracy in quantifying drug concentration. The development of accurate methods for monitoring the temporal evolution of the drug distribution in tissue can advance the real-time light dosimetry in PDT of tumors, leading to better treatment outcomes. Aim: We develop diffuse optical tomography methods based on interstitial fluorescence measurements to accurately reconstruct the spatial distribution of fluorescent photosensitizing drugs in real-time. Approach: A two-stage reconstruction algorithm is proposed. The capabilities and limitations of this method are studied in various simulated scenarios. For the first time, experimental validation is conducted using the clinical system for interstitial PDT of prostate cancer on prostate tissue-mimicking phantoms with the photosensitizer verteporfin. Results: The average relative error of the reconstructed fluorophore absorption was less than 10%, whereas the fluorescent inclusion reconstructed volume relative error was less than 35%. Conclusions: The proposed method can be used to monitor the temporal evolution of the photosensitizing drug concentration in tumor tissue during photodynamic therapy. This is an important step forward in the development of the next generation of real-time light dosimetry algorithms for photodynamic therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.